Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huangshan Zhonghuang Pharmaceutical is a specialized pharmaceutical manufacturer and a subsidiary of Sinopharm (China National Pharmaceutical Group). Based in Huangshan, Anhui Province, the company is a global leader in the production of plant-derived active pharmaceutical ingredients (APIs), specifically flavonoids extracted from Sophora japonica. Its core product portfolio includes Rutin, Troxerutin, and Quercetin, which are essential components in treatments for cardiovascular diseases, chronic venous insufficiency, and inflammatory conditions. The company operates large-scale, GMP-compliant manufacturing facilities and exports its high-purity products to over 30 countries across Europe, North America, and Asia. As a key player in the Sinopharm network, it integrates traditional herbal extraction with modern pharmaceutical standards to serve the global healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huangshan Zhonghuang Pharmaceutical.